Interleukin-18 (interferon-γ-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-γ to inhibit osteoclast formation

Journal of Experimental Medicine

Volumn 185, Issue 6, 1997, Pages 1005-1012

  Udagawa, Nobuyuki ^a   Horwood, Nicole J ^a   Elliott, Jan ^a   Mackay, Alan ^b   Owens, Jane ^b   Okamura, Haruki ^c   Kurimoto, Masashi ^d   Chambers, Timothy J ^b   Martin, T John ^a   Gillespie, Matthew T ^a,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST GEORGE S HOSPITAL   (United Kingdom)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^e ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 11; INTERLEUKIN 18; NEUTRALIZING ANTIBODY; PARATHYROID HORMONE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ARTICLE; CELL CONTACT; CELL CULTURE; CELL POPULATION; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALS; ANIMALS, NEWBORN; BASE SEQUENCE; BONE MARROW CELLS; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; CYTOKINES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-11; INTERLEUKIN-18; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; OSTEOCLASTS; POLYMERASE CHAIN REACTION; RECEPTORS, INTERFERON; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 17544389276     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.185.6.1005     Document Type: Article

References (39)

1. Suda, T., N. Takahashi, and T.J. Martin. 1995. Modulation of osteoclast differentiation: update. In Endocrine Review Monographs. Vol. 4. D.D. Bikle and A. Negrovilar, editors. Endocrine Society, Bethesda, MD. 266-270.
2. Martin, T.J., and K.W. Ng. 1994. Mechanisms by which cells of the osteoblast lineage control osteoclast formation and activity. J. Cell. Biochem. 56:357-366.
3. Suda, T., N. Udagawa, and N. Takahashi. 1996. Cells of bone: osteoclast generation. In Principles of Bone Biology. J.P. Billezikian, L.G. Raisz, G.A. Rodan, editors. Academic Press, San Diego, CA. 87-102.
4. Roodman, G.D. 1996. Advances in bone biology: the osteoclast. Endocrine Rev. 17:308-332.
5. Tamura, T., N. Udagawa, N. Takahashi, C. Miyaura, S. Tanaka, Y. Yamada, Y. Koishihara, Y. Ohsugi, K. Kumaki, T. Taga, et al. 1993. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6. Proc. Natl. Acad. Sci. USA. 90:11924-11928.
6. Udagawa, N., N. Takahashi, T. Katagiri, T. Tamura, S. Wada, D.M. Findlay, T.J. Martin, H. Hirota, T. Taga, T. Kishimoto et al. 1995. IL-6 induction of osteoclast differentiation depends upon IL-6 receptors expressed on osteoblastic cells, but not on osteoclast progenitors. J. Exp. Med. 182:1461-1468.
7. Romas, E., N. Udagawa, H. Zhou, T. Tamura, M. Saito, T. Taga, D.J. Hilton, T. Suda, K.W. Ng, and T.J. Martin. 1996. The role of gp130-mediated signals in osteoclast development: regulation of interleukin 11 production by osteoblasts and distribution of its receptor in bone marrow cultures. J. Exp. Med. 183:2581-2592.
8. Suda, T., N. Takahashi, and T.J. Martin. 1992. Modulation of osteoclast differentiation. Endocrine Rev. 13:66-88.
9. Shioi, A., S.L. Teitelbaum, F.P. Ross, H. Suzuki, J. Ohara, and D.L. Lacey. 1991. Interleukin 4 inhibits murine osteoclast formation in vitro. J. Cell. Biochem. 47:272-277.
10. Lacey, D.L., J.M. Erdmann, S.L. Teitelbaum, H.-L. Tan, J. Ohara, and A. Shioi. 1995. Interleukin 4, interteron-γ, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. Endocrinology. 136:2367-2376.
11. Xu, L.X., T. Kukita, A. Kukita, T. Otsuka, Y. Niho, and T. Iijima. 1995. Interleukin-10 selectively inhibits osteoclasto-genesis by inhibiting differentiation of osteoclast progenitors into preoteoclast-like cells. J. Cell. Physiol. 165:624-629.
12. 3 on osteoclast precursors. J. Bone Miner. Res. 10(Suppl.):S487.
13. Takahashi, N., G.R. Mundy, and G.D. Roodman. 1986. Recombinant human interferon-γ inhibits formation of human osteoclast-like cells. J. Immunol. 137:3544-3549.
14. Horowitz, M.C., and J.A. Lorenzo. 1996. Local regulators of bone: IL-1, TNF, lymphotoxin, interferon-γ, IL-8, IL-10, IL-4 the LIF/IL-6 family, and additional cytokines. In Principles of Bone Biology. J.P. Billezikian, L.G. Raisz, G.A. Rodan, editors. Academic Press, San Diego, CA. 687-700.
15. Nakano, Y., K. Watanabe, I. Morimoto, Y. Okada, K. Ura, K. Sato, K. Kasono, T. Nakamura, and S. Eto. 1994. Interleukm-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice. J. Bone Miner. Res. 9:1533-1539.
16. Hattersley, G., and T.J. Chambers. 1990. The effects of interleukin 3, granulocyte-macrophage-and macrophage-colony stimulating factors on osteoclast differentiation from mouse hemopoietic tissue. J. Cell. Physiol. 142:201-209.
17. Owens, J.M., A.C. Gallagher, and T.J. Chambers. 1996. IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. J. Immunol. 157:936-940.
18. Udagawa, N., N. Takahashi, T. Akatsu, T. Sasaki, A. Yamaguchi, H. Kodama, T.J. Martin, and T. Suda. 1989. The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology. 125:1805-1813.
19. btsA58 transgenic mouse. Proc. Natl. Acad. Sci. USA. 90:5578-5582.
20. Owens, J.M., A.C. Gallagher, and T.J. Chambers. 1996. Bone cells required for osteoclastic resorption but not for osteoclastic differentiation. Biochem. Biophys. Res. Commun. 222:225-229.
21. Liang, P., and A.B. Pardee. 1992. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science (Wash. DC). 257:967-971.
22. Okamura, H., H. Tsutsui, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori et al. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature (Lond.). 378:88-91.
23. Ushio, S., M. Namba, T. Okura, K. Hattori, Y. Nukada, K. Akita, F. Tanabe, K. Konishi, M. Micallef, M. Fujii et al. 1996. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol. 156:4274-4279.
24. Huang, S., W. Hendriks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R.M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-γ receptor. Science (Wash. DC). 259:1742-1745.
25. Takahashi, N., T. Akatsu, N. Udagawa, T. Sasaki, A. Yamaguchi, J.M. Moseley, T.J. Martin, and T. Suda. 1988. Osteoblastic cells are involved in osteoclast formation. Endocrinology. 123: 2600-2602.
26. Takahashi, N., N. Udagawa, T. Akatsu, H. Tanaka, M. Shionome, and T. Suda. 1991. Role of colony-stimulating factors in osteoclast development. J. Bone Miner. Res. 6:977-985.
27. Southby, J., L.M. Murphy, T.J. Martin, and M.T. Gillespie. 1996. Cell-specific and regulator-induced promoter usage and messenger ribonucleic acid splicing for parathyroid hormone-related protein. Endocrinology. 137:1349-1357.
28. Traianedes, K., D.M. Findlay, T.J. Martin, and M.T. Gillespie. 1995. Modulation of the signal recognition particle 54-kDa subunit (SRP54) in rat preosteoblasts by the extracellular matrix. J. Biol. Chem. 270:20891-20894.
29. Tso, J.Y., X.-H. Sun, T.-h. Kao, K.S. Reece, and R. Wu. (1985). Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexicity and molecular evolution of the gene. Nucleic Acids Res. 13:2485-2502.
30. Suda, N., M.T. Gillespie, K. Traianedes, H. Zhou, P.W.M. Ho, D.K. Hards, E.H. Allan, T.J. Martin, and J.M. Moseley. 1996. Expression of parathyroid hormone-related protein in cells of osteoblast lineage. J. Cell. Physiol. 166:94-104.
31. Kurihara, N., and G.D. Roodman. 1990. Interferon-α and -γ inhibit interleukin-1 β-stimulated osteoclast-like cell formation in long-term human marrow cultures. J. Interferon Res. 10:541-547.
32. Takahashi, N., N. Udagawa, T. Akatsu, H. Tanaka, Y. Isogai, and T. Suda. 1991. Deficiency of osteoclasts in osteopetrotic mice is due to a defect in the local microenvironment provided by osteoblastic cells. Endocrinology. 128:1792-
33. Shinar, D.M., M. Sato, and G.A. Rodan. 1990. The effect of hemopoietic growth factors on the generation of osteoclast-like cells in mouse bone marrow cultures. Endocrinology. 126:1728-1735.
34. Shuto, T., T. Kukita, M. Hirata, E. Jimi, and T. Koga. 1994. Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse bone marrow cultures. Endocrinology. 134:1121-1126.
35. Vairo, G., S. Argyriou, K.R. Knight, and J.A. Hamilton. 1991. Inhibition of colony-stimulated macrophage proliferation by tumor necrosis factor-α, IFN-γ, and lipopolysaccharide is not due to a general loss of responsiveness to growth factor. J. Immunol. 146:3469-3477.
36. Gowen, M., G.E. Nedwin, and G.R. Mundy. 1986. Preferential inhibition of cytokine-stimulated bone resorption by recombinant interferon gamma. J. Bone Miner. Res. 1:469-474.
37. Mac-Donald, B.R., G.R. Mundy, S. Clark, E.A. Wang, T.J. Kuehl, E.R. Stanley, and G.D. Roodman. 1986. Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures. J. Bone Mineral. Res. 1:227-233.
38. Bazan, J.F., J.C. Timans, and R.A. Kastelein. 1996. A newly defined interleukin-1? Nature (Lond.). 379:591.
39. Kitazawa, R., R.B. Kimble, J.L. Vannice, V.T. Kung, and R. Pacifici. 1994. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J. Clin. Invest. 94:2397-2406.